EconPapers    
Economics at your fingertips  
 

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups

Oscar M. Rueda, Stephen-John Sammut, Jose A. Seoane, Suet-Feung Chin, Jennifer L. Caswell-Jin, Maurizio Callari, Rajbir Batra, Bernard Pereira, Alejandra Bruna, H. Raza Ali, Elena Provenzano, Bin Liu, Michelle Parisien, Cheryl Gillett, Steven McKinney, Andrew R. Green, Leigh Murphy, Arnie Purushotham, Ian O. Ellis, Paul D. Pharoah, Cristina Rueda, Samuel Aparicio, Carlos Caldas () and Christina Curtis ()
Additional contact information
Oscar M. Rueda: Li Ka Shing Centre, University of Cambridge
Stephen-John Sammut: Li Ka Shing Centre, University of Cambridge
Jose A. Seoane: Stanford University School of Medicine
Suet-Feung Chin: Li Ka Shing Centre, University of Cambridge
Jennifer L. Caswell-Jin: Stanford University School of Medicine
Maurizio Callari: Li Ka Shing Centre, University of Cambridge
Rajbir Batra: Li Ka Shing Centre, University of Cambridge
Bernard Pereira: Li Ka Shing Centre, University of Cambridge
Alejandra Bruna: Li Ka Shing Centre, University of Cambridge
H. Raza Ali: Li Ka Shing Centre, University of Cambridge
Elena Provenzano: Cambridge University Hospital NHS Foundation Trust
Bin Liu: Li Ka Shing Centre, University of Cambridge
Michelle Parisien: Research Institute in Oncology and Hematology
Cheryl Gillett: King’s College London
Steven McKinney: British Columbia Cancer Research Centre
Andrew R. Green: University of Nottingham and Nottingham University Hospital NHS Trust
Leigh Murphy: Research Institute in Oncology and Hematology
Arnie Purushotham: King’s College London
Ian O. Ellis: University of Nottingham and Nottingham University Hospital NHS Trust
Paul D. Pharoah: Li Ka Shing Centre, University of Cambridge
Cristina Rueda: Universidad de Valladolid
Samuel Aparicio: British Columbia Cancer Research Centre
Carlos Caldas: Li Ka Shing Centre, University of Cambridge
Christina Curtis: Stanford University School of Medicine

Nature, 2019, vol. 567, issue 7748, 399-404

Abstract: Abstract The rates and routes of lethal systemic spread in breast cancer are poorly understood owing to a lack of molecularly characterized patient cohorts with long-term, detailed follow-up data. Long-term follow-up is especially important for those with oestrogen-receptor (ER)-positive breast cancers, which can recur up to two decades after initial diagnosis1–6. It is therefore essential to identify patients who have a high risk of late relapse7–9. Here we present a statistical framework that models distinct disease stages (locoregional recurrence, distant recurrence, breast-cancer-related death and death from other causes) and competing risks of mortality from breast cancer, while yielding individual risk-of-recurrence predictions. We apply this model to 3,240 patients with breast cancer, including 1,980 for whom molecular data are available, and delineate spatiotemporal patterns of relapse across different categories of molecular information (namely immunohistochemical subtypes; PAM50 subtypes, which are based on gene-expression patterns10,11; and integrative or IntClust subtypes, which are based on patterns of genomic copy-number alterations and gene expression12,13). We identify four late-recurring integrative subtypes, comprising about one quarter (26%) of tumours that are both positive for ER and negative for human epidermal growth factor receptor 2, each with characteristic tumour-driving alterations in genomic copy number and a high risk of recurrence (mean 47–62%) up to 20 years after diagnosis. We also define a subgroup of triple-negative breast cancers in which cancer rarely recurs after five years, and a separate subgroup in which patients remain at risk. Use of the integrative subtypes improves the prediction of late, distant relapse beyond what is possible with clinical covariates (nodal status, tumour size, tumour grade and immunohistochemical subtype). These findings highlight opportunities for improved patient stratification and biomarker-driven clinical trials.

Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (7)

Downloads: (external link)
https://www.nature.com/articles/s41586-019-1007-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:567:y:2019:i:7748:d:10.1038_s41586-019-1007-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-019-1007-8

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:567:y:2019:i:7748:d:10.1038_s41586-019-1007-8